Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

MEDTRONIC VASCULAR, INC.

US

Last updated September 17, 2026

What MEDTRONIC VASCULAR, INC. makes

The company manufactures non-bioabsorbable soft-tissue mesh anchors, including systems and cassettes for endoscopic or minimally invasive fixation, such as the Heli-FX EndoAnchor System and its thoracic variants. It also produces an introducer sheath with a hydrophilic coating for procedural use.

These devices are regulated under FDA Class II and Class III classifications, with authorisation records in 510(k), PMA, and UDI registries. The company is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Medtronic Vascular, Inc. primarily manufacture?

Medtronic Vascular, Inc. specializes in non-bioabsorbable soft-tissue mesh anchors designed for endoscopic or minimally invasive surgical fixation. Their portfolio includes systems like the Heli-FX EndoAnchor System and its thoracic-specific variants, as well as ancillary components such as cassettes. Additionally, they produce procedural tools like the Sentrant Introducer Sheath with a hydrophilic coating, which reduces friction during insertion.

Where is Medtronic Vascular, Inc. based, and how does that affect its regulatory oversight?

Medtronic Vascular, Inc. is headquartered in the United States, which means its devices fall under the jurisdiction of the U.S. Food and Drug Administration (FDA). The FDA classifies these devices as either Class II or Class III, depending on their risk level and intended use, requiring pre-market authorisation through pathways like 510(k) clearances, Premarket Approvals (PMAs), or Unique Device Identification (UDI) registrations.

Which regulatory registries list Medtronic Vascular, Inc.’s devices, and why?

Medtronic Vascular, Inc.’s devices are listed in the FDA’s 510(k), PMA, and UDI registries. The 510(k) pathway applies to Class II devices deemed substantially equivalent to existing approved products, while Class III devices—often higher-risk—require a Premarket Approval (PMA) to demonstrate safety and effectiveness. The UDI registry ensures traceability and transparency in the supply chain, tracking devices throughout their lifecycle for compliance and recall purposes.

How are Medtronic Vascular, Inc.’s devices classified by the FDA, and what does that mean for their use?

The FDA classifies Medtronic Vascular, Inc.’s devices as either Class II or Class III. Class II devices, like some mesh anchors, typically require performance standards and 510(k) clearance to prove they’re as safe and effective as comparable legacy products. Class III devices, such as certain high-risk fixation systems, require a Premarket Approval (PMA) to demonstrate safety and efficacy through rigorous clinical trials, as they lack a predicate device or pose greater risks.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
3576 Unocal Pl, Santa Rosa, CA, 95403
Website
medtronic.com
LinkedIn
—
Facebook
—
Phone
+1(800)633-8766
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
3001452571
DUNS Number
080009661

Catalogue (509)

Page 7 of 11
DeviceModel / ReferenceRegistriesClassStatus
Cardioblate Monopolar Pen, 60813, Cardioblate Monopolar Xl, 60814 K070288
FDA 510(k)
Class IIActive
Heparin Dose Response Controls, Model 306-20 Por K043080
FDA 510(k)
Class IIActive
Generator, Pulse, Demand, Model 5996 K780741
FDA 510(k)
Class IIIActive
Model 9408 A Teletrace K812703
FDA 510(k)
Class IIActive
DxTerity, DxTerity TRA, DxTerity Angio-Kit, DxTerity EZ-Pak, DxTerity TRA Angio-Kit, DxTerity TRA EZ-Pak K161287
FDA 510(k)
Class IIActive
Medtronic Model 6971 K790074
FDA 510(k)
Class IIIActive
Affinity Nt Hollow Fiber Oxygenator With Plasma Resistant Fiber With Carmeda Bioactive Surface, Model Cb511 K000430
FDA 510(k)
Class IIActive
Medtronic Unipolar, Poly Pac Lead-Barr Coat Coils K913288
FDA 510(k)
Class IIIActive
Reveal Plus Insertable Loop Recorder System, Model 9526 Implanted Recorder And Model 6191 Patient Activator K994331
FDA 510(k)
Class IIActive
6f Taiga Guiding Catheter K083422
FDA 510(k)
Class IIActive
Medtronic Model 6957 K790429
FDA 510(k)
Class IIIActive
6f Z4 Guide Catheter K042489
FDA 510(k)
Class IIActive
Polyether Urethane Material Change In Neurostimulation Leads K040568
FDA 510(k)
Class IIActive
Medtronic Model 3888 Pisces-Quad Plus Lead K923567
FDA 510(k)
Class IIActive
Medtronic Models 3983a And 3983b Resume Leads K921558
FDA 510(k)
Class IIActive
Export Aspiration Catheter K023303
FDA 510(k)
Class IIActive
Canmed 102 K844099
FDA 510(k)
Class IIActive
Minimax Oxygenation System K912655
FDA 510(k)
Class IIActive
Model 6984m Lead Extender Kit K915724
FDA 510(k)
Class IIActive
Neurological Leads (packaging Modification) K940416
FDA 510(k)
Class IIActive
Attain Access 6218 Left-Heart Delivery System, Model 6218 K012083
FDA 510(k)
Class IIActive
Medtronic Stylet Kit, Models 6282, 6293, And 6254 K010906
FDA 510(k)
Class IIActive
Maxima Forte Hollow Fiber Oxygenator With Plasma Resistant Fiber K962641
FDA 510(k)
Class IIActive
Maxima Forte Hardshell Venous Reservoir K961836
FDA 510(k)
Class IIActive
Model 5866-37m Lead Adaptor Kit K904575
FDA 510(k)
Class IIActive
Medtronic A2 Clinical Imaging System K811187
FDA 510(k)
Class IActive
Complete Se Self Expanding Biliary Stent System K062264
FDA 510(k)
Class IIActive
Medtronic Model 6405 K853818
FDA 510(k)
Class IIActive
Neuromed Selectra #7720 K812704
FDA 510(k)
Class IIActive
Respond Ii...neuromuscular Stimulator K813008
FDA 510(k)
Class IIActive
Medtronic Pisces Generation Ii Lead Kit K800193
FDA 510(k)
Class IIActive
Spinal Cord Stimulation Sys Se-4 K833990
FDA 510(k)
Class IIActive
Medtronic Cardiocare Memorytrace Er Model 4221 K912084
FDA 510(k)
Class IIActive
Model 5311b A-V Pacing System Analyzer K910595
FDA 510(k)
Class IIActive
Mastergraft Putty Bone Void Filler K051386
FDA 510(k)
Class IIActive
Medtronic Model 69575 K800944
FDA 510(k)
Class IIIActive
Sentrant Introducer Sheath with Hydrophilic Coating K171866
FDA 510(k)
Class IIActive
Dualscreen K955291
FDA 510(k)
Class IIActive
Medtronic Model 3991, 3991c, 3992, 3992c, 3993, 3993c, 3994, 3994c Leads Or, Transverse Tripolar Leads Or, Ttl K952459
FDA 510(k)
Class IIActive
Alternate Sterile Pkg Implantable Pulse Generators K854482
FDA 510(k)
Class IIIActive
Epicardial, Unipolar Lead 4951 K842065
FDA 510(k)
Class IIActive
Ventricular Lead, Model 6959 K790143
FDA 510(k)
Class IIIActive
Attain Prevail Left Heart Delivery System Moddel, 6228sys K032622
FDA 510(k)
Class IIActive
Implantable Pulse Generators K925106
FDA 510(k)
Class IIActive
Models 6207/6208/6209/6210/6211/6212/6214 (pli's) K900515
FDA 510(k)
Class IIActive
Pulse Generators, Models 5983, 5989 K790068
FDA 510(k)
Class IIIActive
Transvenous Tined Ventricular/Atrial K842031
FDA 510(k)
Class IIIActive
Models 2411/2418 Ventricular-Inhibited K791093
FDA 510(k)
Class IIIActive
Add'l Labeling To Minix Models And Minix St Models K895495
FDA 510(k)
Class IIIActive
Medtronic Model 5866-45 Sizing Sleeve K890644
FDA 510(k)
Class IIIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Medtronic Vascular, Inc. has 234 recall records spanning from June 8, 2004, to March 23, 2022, with statuses recorded as open, classified, or terminated. The reasons cited include mechanical failures such as detachment of spindle components, radiopaque marker bonds, or taper tips during stent graft deployment; labeling errors such as incorrect usable lengths, master labels, and stentstop assemblies; sterility concerns due to compromised package integrity; and manufacturing defects like retained manufacturing materials in embolization systems. Some records reference procedural complications, such as difficulty flushing delivery systems or potential endoleaks and stent fractures.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Mar 23, 2022Z-1043-2022—open, classified

Packaging for Balloon Catheters may be damaged resulting in loss of sterility.

Mar 23, 2022Z-1042-2022—open, classified

Packaging for Balloon Catheters may be damaged resulting in loss of sterility.

Dec 21, 2021Z-0657-2022—open, classified

Stent Graft Systems built with specific batches of taper tip assemblies have the potential for the taper tip to detach from the delivery system. Detachment of the taper tip during the implant procedure may lead to a secondary intervention to attempt to remove the taper tip, either by endovascular retrieval or surgical conversion. There is also potential that the taper tip is intentionally left behind in the patient, at the physician's discretion, if not easily removable.

Oct 15, 2021Z-0291-2022—open, classified

Due to, during stent graft deployment, the spindle may detach from the distal end of the spindle hypotube.

Oct 15, 2021Z-0292-2022—open, classified

Due to, during stent graft deployment, the spindle may detach from the distal end of the spindle hypotube.

Oct 15, 2021Z-0290-2022—open, classified

During stent graft deployment, the spindle may detach from the distal end of the spindle hypotube

Jun 7, 2021Z-2135-2021—open, classified

During stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

Jun 7, 2021Z-2136-2021—open, classified

During product complaint investigation, it was determined that during stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

May 4, 2021Z-1860-2021—terminated

The component part numbers intended for shipment to a third-party, where they are further processed into kits and sterilized were instead shipped directly to customers.

Apr 28, 2021Z-1976-2021—terminated

Incorrect stentstop assembly (18fr) was used to build the delivery system component of the device. Correct stentstop assembly is 20fr.

Feb 12, 2021Z-1201-2021—open, classified

Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.

Jan 15, 2021Z-1248-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1245-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1246-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1247-2021—terminated

Sterility may be compromised due to an unsealed pouch

Aug 25, 2020Z-0088-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Aug 25, 2020Z-0087-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Aug 25, 2020Z-0089-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Mar 15, 2019Z-2605-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2644-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2651-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2749-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2698-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2699-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2732-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2643-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2579-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2574-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2709-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2589-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2575-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2674-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2591-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2604-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2603-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2738-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2562-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2750-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2686-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2688-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2621-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2684-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2721-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2744-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2682-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2733-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2656-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2662-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2647-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2630-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2565-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2654-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2649-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2571-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2635-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2576-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2626-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2692-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2611-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2714-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2633-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2578-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2600-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2618-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2583-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2636-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2752-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2596-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2581-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2726-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2632-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2672-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2593-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2568-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2685-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2652-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2671-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2639-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2585-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2680-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2638-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2710-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2719-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2646-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2718-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2564-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2742-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2594-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2664-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2715-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2717-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2736-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2658-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2650-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2592-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2569-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2597-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2634-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2712-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2747-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.